Table 1.
Expression of select genes implicated in vascular disease
SOCS3+/+ |
SOCS3+/+ |
SOCS3+/− |
SOCS3+/− |
|
---|---|---|---|---|
Gene | + Vehicle | + Ang II | + Vehicle | + Ang II |
eNOS | 1 ± 0.21 | 1.49 ± 0.33 | 0.33 ± 0.17* | 0.54 ± 0.17 |
SOD1 | 1 ± 0.14 | 0.42 ± 0.13* | 0.56 ± 0.12* | 0.40 ± 0.14* |
SOD2 | 1 ± 0.22 | 0.27 ± 0.07* | 0.85 ± 0.05 | 0.34 ± 0.16 |
AT1-R | 1 ± 0.27 | 3.44 ± 0.96 | 2.18 ± 0.36* | 2.32 ± 0.35 |
IL-6 | 1 ± 0.28 | 23.97 ± 9.87* | 0.92 ± 0.55 | 15.34 ± 6.06*† |
Values are means ± SE. Gene expression in aorta from SOCS3+/+ and SOCS3+/− mice systemically treated with vehicle or angiotensin II (Ang II) for 14 days; n = 6,
P < 0.05 vs. vehicle.
P < 0.05 vs. SOCS3+/− plus vehicle.